DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Ristic S, Byiers S, Foley J. et al
Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients
with type 2 diabetes: vildagliptin (LAF237) dose response. Diabetes.
Obesity and Metabolism 2005;
7: 692-698
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.